Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BENCHMARK SPERM: A Prospective, Randomized Controlled Study Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)

NCT06990906 is registered in ClinicalTrials.gov with BAIBYS Fertility as lead sponsor.

NCT NCT06990906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06990906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BENCHMARK SPERM: A Prospective, Randomized Controlled Study Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)
Lead sponsor
BAIBYS Fertility
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 15, 2026
Completion date
October 15, 2026
Enrollment
260 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility, azoospermia